Hyperthyroidism
6 drugs923 FAERS reportsMedDRA PT
GET
/api/v1/reaction/hyperthyroidismReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D006980
Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
Source: U.S. National Library of Medicine — MeSH (Hyperthyroidism)
Drugs reporting Hyperthyroidism (6)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Propylthiouracil1356.7%
- 2Methimazole3985.3%
- 3Amiodarone3523.2%
- 4Hetastarch53.1%
- 5Sodium Iodide312.8%
- 6Landiolol22.5%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Agranulocytosis2 shared · 0.09
- Hypothyroidism2 shared · 0.09
- Cardiogenic Shock2 shared · 0.06
- Exposure During Pregnancy2 shared · 0.04
- Bradycardia2 shared · 0.03
- Maternal Exposure During Pregnancy2 shared · 0.03
- Atrial Fibrillation2 shared · 0.02
- Product Use In Unapproved Indication4 shared · 0.01
- Hypotension4 shared · 0.01
- Drug Interaction3 shared · 0.01
Literature
Recent PubMed references pinned to Hyperthyroidism as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Mouse Model of Graves' Orbitopathy in Current Research and Future Perspectives.Medicina (Kaunas, Lithuania) · 2026 · Lee GM, Jung WH, Kim Y, et al.PMID 42195214DOI 10.3390/medicina62050961
- Development and evaluation of AI model with deep learning for segmentation of extraocular muscles in thyroid eye disease.PloS one · 2026 · Haruna Y, Tagami M, Kurosaki R, et al.PMID 42189850DOI 10.1371/journal.pone.0349074
- Smoking-induced HLA-DQA1 overexpression in T cells: a novel pathway in thyroid eye disease development.Frontiers in immunology · 2026 · Su Y, Cao JPMID 42183209DOI 10.3389/fimmu.2026.1745010
- Lithium carbonate bridging and outcomes of radioiodine therapy in severe Graves' disease: a retrospective cohort study.Frontiers in endocrinology · 2026 · Gao X, Chang W, Sun K, et al.PMID 42181214DOI 10.3389/fendo.2026.1770772
- Association of IL-6 and IL-17 with thyroid eye disease.Frontiers in endocrinology · 2026 · Sun X, Jiang Y, Liu Z, et al.PMID 42181186DOI 10.3389/fendo.2026.1798278
- Ectopic parathyroid carcinoma coexisting with Graves' disease: A case report and literature review.Medicine · 2026 · Li GZ, Li N, Wang ZP, et al.PMID 42152350DOI 10.1097/MD.0000000000048800
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.